Nathan Weinstein
Stock Analyst at Aegis Capital
(0.32)
# 4,052
Out of 4,734 analysts
63
Total ratings
14.52%
Success rate
-24.61%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $1.81 | +4,319.89% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $20 → $15 | $0.71 | +2,012.68% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.63 | +852.38% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $0.95 | +3,584.21% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $2.17 | +176.50% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $2.30 | +1,204.35% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $3.56 | +181.29% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $18.42 | +166.02% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $350 → $10 | $0.34 | +2,862.96% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $4.82 | +44,713.28% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $2.10 | +1,328.57% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $750 → $600 | $0.56 | +107,004.61% | 2 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.10 | +809.09% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $160 | $22.18 | +621.37% | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $26.98 | +107.56% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $1.50 | +1,700.00% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $1.07 | +3,171.03% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.40 | +400.00% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $12.16 | +516.78% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $0.60 | +1,733.33% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $3.01 | +5,880.07% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $0.63 | +1,321.80% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $5.38 | +160.22% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.57 | +1,831.18% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $2.81 | +202.49% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $1.81
Upside: +4,319.89%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $20 → $15
Current: $0.71
Upside: +2,012.68%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.63
Upside: +852.38%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $0.95
Upside: +3,584.21%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.17
Upside: +176.50%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $2.30
Upside: +1,204.35%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $3.56
Upside: +181.29%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $18.42
Upside: +166.02%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $350 → $10
Current: $0.34
Upside: +2,862.96%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $4.82
Upside: +44,713.28%
Dec 7, 2021
Initiates: Buy
Price Target: $30
Current: $2.10
Upside: +1,328.57%
Nov 15, 2021
Maintains: Buy
Price Target: $750 → $600
Current: $0.56
Upside: +107,004.61%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $1.10
Upside: +809.09%
Sep 22, 2021
Maintains: Buy
Price Target: $180 → $160
Current: $22.18
Upside: +621.37%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $26.98
Upside: +107.56%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $1.50
Upside: +1,700.00%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $1.07
Upside: +3,171.03%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $2.40
Upside: +400.00%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $12.16
Upside: +516.78%
Oct 19, 2020
Maintains: Buy
Price Target: $13 → $11
Current: $0.60
Upside: +1,733.33%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $3.01
Upside: +5,880.07%
Aug 3, 2020
Maintains: Buy
Price Target: $13 → $9
Current: $0.63
Upside: +1,321.80%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $5.38
Upside: +160.22%
May 4, 2020
Maintains: Buy
Price Target: $9 → $11
Current: $0.57
Upside: +1,831.18%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $2.81
Upside: +202.49%